Literature DB >> 22101736

A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect.

Yi-Qing Yang1, Li Li, Juan Wang, Xing-Yuan Liu, Xiao-Zhong Chen, Wei Zhang, Xiao-Zhou Wang, Jin-Qi Jiang, Xu Liu, Wei-Yi Fang.   

Abstract

Ventricular septal defect (VSD) is the most prevalent type of congenital heart disease and a major cause for the significantly increased morbidity and mortality among infants. Aggregating evidence indicates that genetic defects are involved in the pathogenesis of congenital VSD. Nevertheless, VSD is genetically heterogeneous, and the genetic determinants for VSD in the majority of patients remain to be identified. In this study, the entire coding region of GATA4, a gene encoding a zinc finger transcription factor essential for normal cardiac morphogenesis, was sequenced in 160 unrelated patients with VSD. The available relatives of the index patient harboring the identified mutation and 200 unrelated control individuals were subsequently genotyped. The disease-causing potential of a sequence alteration was evaluated by MutationTaster, and the functional effect of the mutation was characterized using a luciferase reporter assay system. As a result, a novel heterozygous GATA4 variation, p.R43W, was identified in a proband with VSD, that was absent in control subjects. Genetic analysis of the family members of the variation carrier showed that the substitution co-segregated with VSD. The p.R43W variant was predicted to be a pathogenic mutation, and the functional analysis demonstrated that the GATA4 R43W mutant protein resulted in significantly decreased transcriptional activity compared with its wild-type counterpart. The findings expand the mutational spectrum of GATA4 linked to VSD and provide more insight into the molecular mechanism of VSD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101736     DOI: 10.1007/s00246-011-0146-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  47 in total

1.  GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart.

Authors:  S M Reamon-Buettner; J Borlak
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

Review 2.  GATA factors in vertebrate heart development and disease.

Authors:  Alison Brewer; John Pizzey
Journal:  Expert Rev Mol Med       Date:  2006-09-15       Impact factor: 5.600

Review 3.  Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions.

Authors:  Robert J Sommer; Ziyad M Hijazi; John F Rhodes
Journal:  Circulation       Date:  2008-02-26       Impact factor: 29.690

4.  The development and structure of the ventricles in the human heart.

Authors:  Deborah J Henderson; Robert H Anderson
Journal:  Pediatr Cardiol       Date:  2009-02-19       Impact factor: 1.655

5.  Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.

Authors:  Kayoko Hirayama-Yamada; Mitsuhiro Kamisago; Kaoru Akimoto; Hiroyuki Aotsuka; Yoshihide Nakamura; Hideshi Tomita; Michiko Furutani; Shin-ichiro Imamura; Atsuyoshi Takao; Makoto Nakazawa; Rumiko Matsuoka
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

6.  A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect.

Authors:  Yu Chen; Zeng-Qiang Han; Wei-Dong Yan; Chu-Zhong Tang; Ji-Yan Xie; Hong Chen; Da-Yi Hu
Journal:  J Thorac Cardiovasc Surg       Date:  2010-03-26       Impact factor: 5.209

7.  GATA4 transcription factor is required for ventral morphogenesis and heart tube formation.

Authors:  C T Kuo; E E Morrisey; R Anandappa; K Sigrist; M M Lu; M S Parmacek; C Soudais; J M Leiden
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

8.  Involvement of a novel GATA4 mutation in atrial septal defects.

Authors:  Xing-Yuan Liu; Juan Wang; Jing-Hao Zheng; Kai Bai; Zhong-Min Liu; Xiao-Zhou Wang; Xu Liu; Wei-Yi Fang; Yi-Qing Yang
Journal:  Int J Mol Med       Date:  2011-03-03       Impact factor: 4.101

9.  Anterior endoderm is sufficient to rescue foregut apoptosis and heart tube morphogenesis in an embryo lacking retinoic acid.

Authors:  S Ghatpande; A Ghatpande; M Zile; T Evans
Journal:  Dev Biol       Date:  2000-03-01       Impact factor: 3.582

Review 10.  The roles of GATA-4, -5 and -6 in vertebrate heart development.

Authors:  Tessa Peterkin; Abigail Gibson; Matthew Loose; Roger Patient
Journal:  Semin Cell Dev Biol       Date:  2004-12-15       Impact factor: 7.727

View more
  14 in total

1.  Novel GATA6 mutations associated with congenital ventricular septal defect or tetralogy of fallot.

Authors:  Juan Wang; Xue-Jiao Luo; Yuan-Feng Xin; Yi Liu; Zhong-Min Liu; Qian Wang; Ruo-Gu Li; Wei-Yi Fang; Xiao-Zhou Wang; Yi-Qing Yang
Journal:  DNA Cell Biol       Date:  2012-09-28       Impact factor: 3.311

Review 2.  The genetics of isolated congenital heart disease.

Authors:  Shannon N Nees; Wendy K Chung
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-12-26       Impact factor: 3.908

3.  Congenital diaphragmatic hernia interval on chromosome 8p23.1 characterized by genetics and protein interaction networks.

Authors:  Mauro Longoni; Kasper Lage; Meaghan K Russell; Maria Loscertales; Omar A Abdul-Rahman; Gareth Baynam; Steven B Bleyl; Paul D Brady; Jeroen Breckpot; Chih P Chen; Koenraad Devriendt; Gabriele Gillessen-Kaesbach; Arthur W Grix; Alan F Rope; Osamu Shimokawa; Bernarda Strauss; Dagmar Wieczorek; Elaine H Zackai; Caroline M Coletti; Faouzi I Maalouf; Kristin M Noonan; Ji H Park; Adam A Tracy; Charles Lee; Patricia K Donahoe; Barbara R Pober
Journal:  Am J Med Genet A       Date:  2012-11-19       Impact factor: 2.802

Review 4.  Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders.

Authors:  Terence Prendiville; Patrick Y Jay; William T Pu
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

5.  GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect.

Authors:  Dong Wei; Han Bao; Ning Zhou; Gui-Fen Zheng; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2012-09-09       Impact factor: 1.655

6.  Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.

Authors:  En-hai Cui; Hong-jiao Li; Feng Hua; Bin Wang; Wei Mao; Xue-ren Feng; Jian-you Li; Xiang Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

7.  [Establishment and verification of a mouse model of Gata4 gene H435Y mutation].

Authors:  Hui Zhang; Mingwu Chen; Tao Fang; Tian Zhang; Wenqian Ni
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

8.  The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease.

Authors:  Dorothy Warburton; Michael Ronemus; Jennie Kline; Vaidehi Jobanputra; Ismee Williams; Kwame Anyane-Yeboa; Wendy Chung; Lan Yu; Nancy Wong; Danielle Awad; Chih-Yu Yu; Anthony Leotta; Jude Kendall; Boris Yamrom; Yoon-Ha Lee; Michael Wigler; Dan Levy
Journal:  Hum Genet       Date:  2013-08-25       Impact factor: 4.132

9.  Genetic mutation analysis in Japanese patients with non-syndromic congenital heart disease.

Authors:  Akiko Yoshida; Hiroko Morisaki; Mai Nakaji; Masataka Kitano; Ki-Sung Kim; Koichi Sagawa; Shiro Ishikawa; Ichiro Satokata; Yoshihide Mitani; Hitoshi Kato; Kenji Hamaoka; Shigeyuki Echigo; Isao Shiraishi; Takayuki Morisaki
Journal:  J Hum Genet       Date:  2015-10-22       Impact factor: 3.172

10.  GATA5 loss-of-function mutations underlie tetralogy of fallot.

Authors:  Dong Wei; Han Bao; Xing-Yuan Liu; Ning Zhou; Qian Wang; Ruo-Gu Li; Ying-Jia Xu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2012-12-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.